Background: Phosphatase and tensin homolog (PTEN) germline mutations are associated with cancer syndromes (PTEN hamartoma tumor syndrome; PHTS) and in pediatric patients with autism spectrum disorder (ASD) and macrocephaly. The exact prevalence of PTEN mutations in patients with ASD and macrocephaly is uncertain; with prevalence rates ranging from 1% to 17%. Most studies are retrospective and contain more adult than pediatric patients, there is a need for more prospective pediatric studies.Methods: We recruited 131 patients (108 males, 23 females) with ASD and macrocephaly between the ages of 3 and 18 from five child and adolescent psychiatry clinics in Turkey from July 2018 to December 2019. We defined macrocephaly as occipito‐frontal HC size at or greater than 2 standard deviations (SD) above the mean for age and sex on standard growth charts. PTEN gene sequence analysis was performed using a MiSeq next generation sequencing (NGS) platform, (Illumina).Conclusion: PTEN gene sequence analyses identified three pathogenic/likely pathogenic mutations [NM_000314.6; p.(Pro204Leu), (p.Arg233*) and novel (p.Tyr176Cys*8)] and two variants of uncertain significance (VUS) [NM_000314.6; p.(Ala79Thr) and c.*10del]. We also report that patient with (p.Tyr176Cys*8) mutation has Grade 1 hepatosteatosis, a phenotype not previously described. This is the first PTEN prevalence study of patients with ASD and macrocephaly in Turkey and South Eastern Europe region with a largest homogenous cohort. The prevalence of PTEN mutations was found 3.8% (VUS included) or 2.29% (VUS omitted). We recommend testing for PTEN mutations in all patients with ASD and macrocephaly.
23 February 2021 in Waste and Biomass Valorization
Understanding cellular regulation of metabolism is a major challenge in systems biology. Thus far, the main assumption was that enzyme levels are key regulators in metabolic networks. However, regulation analysis recently showed that metabolism is rarely controlled via enzyme levels only, but through non-obvious combinations of hierarchical (gene and enzyme levels) and metabolic regulation (mass action and allosteric interaction). Quantitative analyses relating changes in metabolic fluxes to changes in transcript or protein levels have revealed a remarkable lack of understanding of the regulation of these networks. We study metabolic regulation via feasibility analysis (FA). Inspired by the constraint-based approach of Flux Balance Analysis, FA incorporates a model describing kinetic interactions between molecules. We enlarge the portfolio of objectives for the cell by defining three main physiologically relevant objectives for the cell: function, robustness and temporal responsiveness. We postulate that the cell assumes one or a combination of these objectives and search for enzyme levels necessary to achieve this. We call the subspace of feasible enzyme levels the feasible enzyme space. Once this space is constructed, we can study how different objectives may (if possible) be combined, or evaluate the conditions at which the cells are faced with a trade-off among those. We apply FA to the experimental scenario of long-term carbon limited chemostat cultivation of yeast cells, studying how metabolism evolves optimally. Cells employ a mixed strategy composed of increasing enzyme levels for glucose uptake and hexokinase and decreasing levels of the remaining enzymes. This trade-off renders the cells specialized in this low-carbon flux state to compete for the available glucose and get rid of over-overcapacity. Overall, we show that FA is a powerful tool for systems biologists to study regulation of metabolism, interpret experimental data and evaluate hypotheses.
30 March 2011 in Mathematical and Computer Modelling of Dynamical Systems
Construction of dynamic models of large-scale metabolic networks is one of the central issues in the engineering of living cells. However, construction of such models is often hampered by a number of challenges, for example, data availability, compartmentalization and parameter identification coupled with design of in vivo perturbations. As a solution to the latter, short-term perturbation experiments are proposed and are proven to be a useful experimental method to obtain insights into the in vivo kinetic properties of the metabolic pathways. The aim of this work is to construct a kinetic model using the available experimental data obtained by short-term perturbation experiments, where the steady state of a glucose-limited anaerobic chemostat culture of Saccharomyces cerevisiae was perturbed. In constructing the model, we first determined the steady-state flux distribution using the data before the glucose pulse and the known stoichiometry. For the rate expressions, we used approximative linlog kinetics, which allows the enzyme–metabolite kinetic interactions to be represented by an elasticity matrix. We performed a priori model reduction based on timescale analysis and parameter identifiability analysis allowing the information content of the experimental data to be assessed. The final values of the elasticities are estimated by fitting the model to the available short-term kinetic response data. The final model consists of 16 metabolites and 14 reactions. With 25 parameters, the model adequately describes the short-term response of the cells to the glucose perturbation, pointing to the fact that the assumed kinetic interactions in the model are sufficient to account for the observed response.
1 June 2018 in Journal of microbiology, biotechnology and food sciences